New Cosponsors — Jun 6, 2012
New Cosponsor: Rep. Michael “Mike” Honda [D-CA17]
New Cosponsor: Rep. Steven Rothman [D-NJ9, 1997-2012]
Feb 2, 2012
112th Congress, 2011–2013
This bill was introduced on February 2, 2012, in a previous session of Congress, but was not enacted.
Representative for Massachusetts's 7th congressional district
Read Text »
Last Updated: Feb 2, 2012
Length: 16 pages
To amend the Public Health Service Act to speed American innovation in research and drug development for the leading causes of death that are the most costly chronic conditions for our Nation, to save American families and the Federal and State governments money, and to help family caregivers.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Feb 2, 2012
The “H.R.” in “H.R. 3891” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 3891 — 112th Congress: Spending Reductions through Innovations in Therapies Agenda Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/hr3891
“H.R. 3891 — 112th Congress: Spending Reductions through Innovations in Therapies Agenda Act of 2012.” www.GovTrack.us. 2012. May 30, 2015 <https://www.govtrack.us/congress/bills/112/hr3891>
|title=H.R. 3891 (112th)
|accessdate=May 30, 2015
|author=112th Congress (2012)
|date=February 2, 2012
|quote=Spending Reductions through Innovations in Therapies Agenda Act of 2012